Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer

NCT03755141 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

109

Enrollment

OTHER_GOV

Sponsor class

Conditions

HER2-positive Breast Cancer
Metastatic Breast Cancer

Interventions

DRUG: Herzuma

Sponsor

National Cancer Center, Korea